Resist the urge to short healthcare stocks as they print new ATHs this year

- People are advised not to buy puts on $LLY, $NVO, $HIMS, and other pharmaceutical companies due to the belief that their stock prices are already high and may face competition reducing earnings - $LLY is predicted to become the first trillion-dollar healthcare company with breakthroughs in GLP1 and longevity, potentially driving widespread fear of missing out in the market - Healthcare is seen as a sector that will continue to see increased spending in a world becoming more automated, leading to potential growth opportunities - The future is predicted to involve more spending on healthcare for various reasons, such as signaling status or improving overall well-being, especially as other aspects of life become cheaper - Even if the optimistic future of increased healthcare spending doesn't play out, if the market believes it will, put options could be unsuccessful